Is anyone else worried about the 8.8% SAEs compared to 4.5% for the comparator arm? Granted, everything looks significantly better with Pix, but will that 8.8% be an issue with the FDA? I don't know where to get information for this type of thing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.